D.E. Shaw & Co’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-110,552
| Closed | -$86K | – | 4115 |
|
2022
Q2 | $86K | Buy |
+110,552
| New | +$86K | ﹤0.01% | 3581 |
|
2022
Q1 | – | Sell |
-33,682
| Closed | -$270K | – | 4430 |
|
2021
Q4 | $270K | Buy |
+33,682
| New | +$270K | ﹤0.01% | 3357 |
|
2021
Q1 | – | Sell |
-12,591
| Closed | -$53K | – | 3141 |
|
2020
Q4 | $53K | Sell |
12,591
-5,940
| -32% | -$25K | ﹤0.01% | 2672 |
|
2020
Q3 | $89K | Buy |
18,531
+907
| +5% | +$4.36K | ﹤0.01% | 2491 |
|
2020
Q2 | $107K | Sell |
17,624
-7,760
| -31% | -$47.1K | ﹤0.01% | 2529 |
|
2020
Q1 | $139K | Sell |
25,384
-25,606
| -50% | -$140K | ﹤0.01% | 2515 |
|
2019
Q4 | $506K | Buy |
+50,990
| New | +$506K | ﹤0.01% | 2187 |
|
2019
Q1 | – | Sell |
-21,436
| Closed | -$338K | – | 2689 |
|
2018
Q4 | $338K | Sell |
21,436
-49,250
| -70% | -$777K | ﹤0.01% | 2214 |
|
2018
Q3 | $1.37M | Buy |
+70,686
| New | +$1.37M | ﹤0.01% | 1699 |
|
2016
Q2 | – | Sell |
-11,663
| Closed | -$57K | – | 2642 |
|
2016
Q1 | $57K | Sell |
11,663
-13,713
| -54% | -$67K | ﹤0.01% | 2522 |
|
2015
Q4 | $220K | Sell |
25,376
-5,545
| -18% | -$48.1K | ﹤0.01% | 2393 |
|
2015
Q3 | $451K | Sell |
30,921
-8,072
| -21% | -$118K | ﹤0.01% | 2085 |
|
2015
Q2 | $650K | Buy |
38,993
+23,187
| +147% | +$387K | ﹤0.01% | 2063 |
|
2015
Q1 | $346K | Buy |
+15,806
| New | +$346K | ﹤0.01% | 2204 |
|